Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: Aegis Conference

PharmAthene, Inc. (PIP) Starts Presentation at the Aegis Healthcare Conference

PharmAthene, Inc. is a biodefense company developing medical countermeasures against biological and chemical threats. The company’s product candidates include: SparVax, an anthrax vaccine which has completed a Phase II clinical trial for post-exposure prophylaxis; Valortim, a human monoclonal antibody which … Continue reading

Posted in Aegis Conference | Leave a comment

Mast Therapeutics, Inc. (MSTX) Starts Presentation at the Aegis Healthcare Conference

Mast Therapeutics, Inc. (NYSE: MSTX) is a biopharmaceutical company developing therapies for life-threatening diseases. The company’s lead product candidate is MST-188, which has hemorheologic, cytoprotective, and anti-inflammatory properties and is in phase 3 study for the treatment of sickle cell … Continue reading

Posted in Aegis Conference | Leave a comment

Catalyst Pharmaceutical Partners, Inc. (CPRX) Starts Presentation at the Aegis Healthcare Conference

Catalyst Pharmaceutical Partners, Inc. is a specialty pharmaceutical company developing prescription drugs targeting rare neuromuscular and neurological diseases and disorders. The company’s principal product is Firdapse, which is in Phase III clinical trial for the treatment of Lambert-Eaton Myasthenic Syndrome. … Continue reading

Posted in Aegis Conference | Leave a comment

Targeted Medical Pharma, Inc. (TRGM) Starts Presentation at the Aegis Healthcare Conference

Targeted Medical Pharma, Inc. is a biotechnology company that develops and distributes prescription medical foods for chronic disease treatment, convenience kits, and generic pharmaceuticals to physicians and pharmacies in the United States and Middle East. The company also provides technical … Continue reading

Posted in Aegis Conference | Leave a comment

PhotoMedex, Inc. (PHMD) Starts Presentation at the Aegis Healthcare Conference

PhotoMedex, Inc. is a skin health company that provides integrated disease management and aesthetic solutions to dermatologists, professional aestheticians, and consumers. The company offers products and services that address skin diseases and conditions, including psoriasis and acne, and provides skin … Continue reading

Posted in Aegis Conference | Leave a comment

Regado Biosciences, Inc. (RGDO) Starts Presentation at the Aegis Healthcare Conference

Regado Biosciences, Inc. is a biopharmaceutical company discovering and developing antithrombotic drug systems for acute and sub-acute cardiovascular and other indications. The company’s lead product includes REG1, an anticoagulant in clinical trials for use in patients with cardiovascular conditions who … Continue reading

Posted in Aegis Conference | Leave a comment

Can-Fite BioPharma, Ltd. (CANFY) Starts Presentation at the Aegis Healthcare Conference

Can-Fite BioPharma, Ltd. is a biotechnology company developing drugs for treating cancer and autoimmune inflammatory diseases. Principally, the company develops CF101, which is in Phase III study for the treatment of psoriasis and has completed Phase II study for the … Continue reading

Posted in Aegis Conference | Leave a comment

Enzo Biochem, Inc. (ENZ) Starts Presentation at the Aegis Healthcare Conference

Enzo Biochem, Inc. is an integrated life sciences and biotechnology company that focuses on diagnostic and research products. The company operates in three segments: the Clinical Labs segment offers clinical laboratory tests/procedures used in general patient care; the Life Sciences … Continue reading

Posted in Aegis Conference | Leave a comment

Atossa Genetics, Inc. (ATOS) Starts Presentation at the Aegis Healthcare Conference

Atossa Genetics, Inc. is a healthcare company developing and marketing cellular and molecular diagnostic risk assessment products for breast cancer. The company’s diagnostic tests include the ForeCYTE Breast Health Test, which provides personalized information about the 10-year and lifetime risk … Continue reading

Posted in Aegis Conference | Leave a comment

Trovagene Inc. (TROV) Starts Presentation at the Aegis Healthcare Conference

Trovagene Inc. (NASDAQ: TROV) develops diagnostic technologies for use in patient/disease screening and monitoring in various medical disciplines. The company’s urine-based testing platform helps to enhance cancer care management and women’s healthcare. The company’s technology is also applied in various … Continue reading

Posted in Aegis Conference | Leave a comment